flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 clinical (funded by Novo Nordisk): showed 24% reduction in the risk of FLOW- the Visual Abstract —

For DunedinPACE, which is already a per-year rate, we computed the change between Week 32 and baseline values (so a negative change indicates slowing of aging)

Excretion Mainly excreted through urine and bile, with a half-life of approximately 6 to 8 hours

GLP1s do not interact significantly with antiretroviral therapy

Supporting this mechanism, studies in animal models demonstrate that L-carnitine administration increases the expression of mitochondrial superoxide dismutase-2 (SOD2), reduces markers of inflammation, and alleviates overall oxidative burden (63)

Vitamin B12 is a vital nutrient that helps your body make red blood cells and maintain healthy nerve function